You have Guest access.
Log In
Letters to the Editor
A. J. M. Loonen, C. H. Doorschot, L. P. Van Bavel, B. Groot, H. J. E. M. De Blok, L. J. Krijgsman, P. H. M. Van Dongen, A. A. M. Jaspers and L. C. C. Vanbrabant
Journal Article
A comparison of carbamazepine divitabs with carbamazepine normal formulation in psychiatric and oligophrenic patients Preliminary pharmacokinetic results
Anton J. M. Loonen, Peter J. M. M. Toll and Jan R. Nijdam
Pharmacy World & Science, 1989, Volume 11, Number 1, Pages 23-26
Epileptic seizures and lipoma of the corpus callosum
E. Grasso, P. C. Gerbino Promis, A. Cognazzo, D. Seliak and P. Zagnoni
The Italian Journal of Neurological Sciences, 1982, Volume 3, Number 2, Pages 139-142
Computer analysis of saccadic eye movements: assessment of two different carbamazepine formulations
G. Tedeschi, G. Casucci, S. Allocca, R. Riva and A. Costanzo, et al.
European Journal of Clinical Pharmacology, 1989, Volume 37, Number 5, Pages 513-516
The daily rhythm of HVA, VMA, (VA) and 5-HIAA in depressionsyndrom
P. Riederer, W. Birkmayer, E. Neumayer, L. Ambrozi and W. Linauer
Journal of Neural Transmission, 1974, Volume 35, Number 1, Pages 23-45
Effect of carbamazepine on psychomotor performance in näive subjects
G. J. A. MacPhee, C. Goldie, D. Roulston, L. Potter and E. Agnew, et al.
European Journal of Clinical Pharmacology, 1986, Volume 30, Number 1, Pages 37-42
Book Chapter
Medikamente zur Behandlung bipolarer affektiver Störungen
Heinz Grunze and Anna Forsthoff
2008, Handbuch der Psychopharmakotherapie, V, Pages 555-590
Bioavailability of controlled release carbamazepine estimated by mixed effect modelling
R. Miller and T. M. Ludden
European Journal of Clinical Pharmacology, 1993, Volume 44, Number 3, Pages 231-235
Pharmacokinetics of carbamazepine derived from a new tablet formulation
J. Popović, M. Mikov and V. Jakovljevic
European Journal of Drug Metabolism and Pharmacokinetics, 1995, Volume 20, Number 4, Pages 297-300
Evaluation of Different Metrics as Indirect Measures of Rate of Drug Absorption from Extended Release Dosage Forms at Steady-State
Cristos Reppas, Larry F. Lacey, Oliver N. Keene, Panos Macheras and Alan Bye
Pharmaceutical Research, 1995, Volume 12, Number 1, Pages 103-107
Alpha1-acid glycoprotein concentration and serum protein binding of carbamazepine and carbamazepine-10,11 epoxide in children with epilepsy
M. Contin, R. Riva, F. Albani, E. Perucca and G. Lamontanara, et al.
European Journal of Clinical Pharmacology, 1985, Volume 29, Number 2, Pages 211-214
Keywords Carbamazepine - Clinical trials - Cognition disorders - Drug compounding - Psychiatry
Frequently asked questions General info on journals and books Send us your feedback Impressum Contact us
© Springer, Part of Springer Science+Business Media Privacy, Disclaimer, Terms & Conditions, and Copyright Info